Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-300
Closed -$405 1295
2026
Q1
$405 Buy
+300
New +$16.3K ﹤0.01% 1252

Other funds holding GSK

IHT Wealth Management's GSK Position: Q2 2026 in Review

IHT Wealth Management reduced its GSK (GSK) stake by 1.6% in Q2 2026, selling an estimated $15.9K and leaving 17,974 shares worth $942K. The position accounts for 0.02% of the portfolio, ranked #623.

IHT Wealth Management first reported a position in GSK in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.05M in Q4 2019. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • IHT Wealth Management held 17,974 shares of GSK worth $942K as of Q2 2026.
  • IHT Wealth Management sold 301 GSK shares in Q2 2026, an estimated $15.9K.
  • GSK made up 0.02% of IHT Wealth Management's portfolio in Q2 2026, its #623 holding.
  • IHT Wealth Management first reported a position in GSK in Q4 2016 and has held it in 39 quarters since.
  • IHT Wealth Management's GSK position peaked at $1.05M in Q4 2019.
  • 1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on IHT Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.